Vitiligo. Vitiligo
Conditions
Interventions
Intervention 1: Intervention group: clobetasol 0.05% (Raha Pharmaceutical Co., Iran) daily on the lesions remaining for at least 3 hours while avoiding direct sun exposure. Intervention 2: Interventio
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 16-60 years Involvement of <20% total body surface area Lesions on the extremities, trunk, and face
Exclusion criteria
Exclusion criteria: Follicular pigmentation White hair in the lesion Lesions at the distal end of the extremities Genital, periungual, and skin fold lesions Topical treatment or phototherpay within the past month Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perifollicular pigmentation improvement. Timepoint: Three months after the initiation of treatments. Method of measurement: 1) mild: 0-25%, 2) moderate: 26-50%, 3) good: 50-75%, 4) excellent: >75%. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction with treatments. Timepoint: Three months after the initiation of treatments. Method of measurement: Visual Analogue Scale.;Side effects. Timepoint: During treatments. Method of measurement: Patient reports of observation by the specialist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAida Farmani
Esfahan University of Medical Sciences
Outcome results
None listed